By Neha MathurJun 27 2023Reviewed by Lily Ramsey, LLM In a recent study published in the Journal of Infection, researchers performed a systematic literature review of global treatment outcomes of extensively drug-resistant Tuberculosis.
Its treatment includes daily injections for 18 months or more, which makes it not only costly but tedious health condition to treat. Furthermore, treatment outcomes are poorer for cases of lesser drug-resistant strains of Mycobacterium tuberculosis. Now novel and promising treatment options for drug-resistant Tuberculosis have emerged, though access to healthcare and acquired drug resistance is still a concern. Thus, researchers aimed to determine the proportion of extensively drug-resistant tuberculosis patients who attained successful treatment outcomes up to 2023 using data published by WHO.
Overall, they found 94 studies from 26 nations with a total sample size of 10,223 patients who suffered from extensively drug-resistant Tuberculosis. It is an oral, six-month regimen for highly drug-resistant Tuberculosis, where a patient receiving BPaL for 26 weeks typically attains a successful treatment outcome.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Unveiling the truth: tropical hunter-gatherers' diets contradict Paleo diet assumptionsUnveiling the truth: tropical hunter-gatherers' diets contradict Paleo diet assumptions AJCNutrition huntergatherer diet paleo paleodiet tropical
Source: NewsMedical - 🏆 19. / 71 Read more »
Unveiling the link: gut microbiome, diet, and SARS-CoV-2 infectionsUnveiling the link: gut microbiome, diet, and SARS-CoV-2 infections microbiome gutmicrobiome guthealth covid COVID19 SARSCoV2
Source: NewsMedical - 🏆 19. / 71 Read more »